Table 2.
Univeriate and multivariate analyses of the predictive factors related to evaluation of cold tumour immune status.
| Factors | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P-value | OR | 95% CI | P-value | |
| Age (<73/≧73) (yr.) | 0.65 | 0.22–1.82 | 0.41 | – | – | – |
| Gender (male/female) | 2.25 | 0.78–6.50 | 0.13 | 4.71 | 1.18–18.7 | 0.03 |
| Tumour size (<2 cm/≧2 cm) | 1.31 | 0.4–4.28 | 0.65 | – | – | – |
| T factor (T1, 2/T3, 4) | 1.03 | 0.35–3.03 | 0.96 | – | – | – |
| N factor (negative/positive) | 0.65 | 0.11–3.88 | 0.64 | – | – | – |
| Lymphatic invasion (negative/positive) | 0.45 | 0.14–1.42 | 0.17 | 1.31 | 0.17–9.93 | 0.79 |
| Venous invasion (negative/positive) | 0.53 | 0.14–1.97 | 0.34 | 2.18 | 0.21–22.1 | 0.51 |
| Y–K classification (1, 2, 3/4 C, 4D) | 3.56 | 1.14–11.12 | 0.029 | 7.39 | 1.57–34.7 | 0.01 |
| Levels of FDG-uptake (Low/High) | 10 | 1.96–51.1 | 0.006 | 29.17 | 2.79–304.2 | 0.005 |
OR odds ratio, CI confidence interval.